Physician

David Robert Fermin, M.D.

According to 2025 Medicare claims, David Fermin, M.D. (NPI: 1447442215) practices advanced heart failure and transplant cardiology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is SPECTRUM HEALTH PRIMARY CARE PARTNERS (NPI: 1235188673; TIN: 381358164) and primary practice location at 49503-2560. Fermin is affiliated with the POM ACO (ACO ID: A1297) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Fermin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 286 traditional Medicare patients, billed 646 HCPCS/CPT codes, and received $36,189 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,793 prescription claims across 522 beneficiaries totaling $7,397,021 in drug costs, led by Vyndamax (Tafamidis). 2021 DME data shows 132 claims. Open Payments data shows 25 records totaling $335,893. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $70,685 to $36,189. In contrast, Part D prescription costs have moved sharply higher in recent years, from $146,602 to $7,397,021. For DME billing, this smaller-volume category declined steadily, from $13,234 to $8,546.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	330	1,284	$70,685
2016	375	1,357	$72,033
2017	721	1,448	$59,683
2018	689	1,258	$56,892
2019	473	932	$43,147
2020	612	1,013	$42,576
2021	430	787	$44,657
2022	285	522	$30,087
2023	489	801	$37,724
2024	286	646	$36,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	175	629	$146,602
2016	167	677	$77,254
2017	161	691	$66,631
2018	187	783	$96,953
2019	238	1,189	$432,687
2020	262	1,479	$450,740
2021	356	1,989	$711,458
2022	437	2,754	$2,111,460
2023	464	2,789	$2,945,362
2024	522	2,793	$7,397,021

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	176	$156,329
2016	N/R	318	$245,027
2017	N/R	183	$14,646
2018	N/R	206	$12,120
2019	N/R	198	$15,727
2020	N/R	160	$12,634
2021	N/R	132	$9,898
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	33	47	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	65	74	$77
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	38	39	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	77	83	$13
G0250	Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent	39	42	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	256	8,520	$6,421,107
Entresto	Sacubitril/Valsartan	179	10,357	$210,051
Eliquis	Apixaban	184	11,045	$203,447
Camzyos	Mavacamten	25	725	$201,211
Farxiga	Dapagliflozin Propanediol	185	8,793	$158,647

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$12,480	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$323,413	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Robert Fermin, M.D.?

Tedicare shows public-source Medicare data for David Robert Fermin, M.D. (NPI 1447442215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Robert Fermin, M.D. have ACO affiliation data?

David Robert Fermin, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to David Robert Fermin, M.D.?

David Robert Fermin, M.D. is linked to SPECTRUM HEALTH PRIMARY CARE PARTNERS (billing NPI 1235188673) in the available physician profile data.

Does David Robert Fermin, M.D. have Open Payments data?

David Robert Fermin, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.